In this episode of the podcast, Dr Aleksandra Zuraw interviews Dr Ralf Huss about digital pathology in clinical practice. They discuss the benefits of going digital, how to start the digital pathology journey, the role of pathologists in digital transformation, and how digital pathology is important for evaluating complex biomarkers and advancing immuno-oncology programs.

Further reading

Implementing digital pathology into clinical practice is a significant task, discussed by Dr Ralf Huss, chairman of Visiopharm’s advisory board. He shares his insights from his diverse experience in academia, big pharma, small startups, and hospital practice. The key to a successful transition to digital pathology is to provide interoperable tools that can be integrated into a functional pathology workflow. Labs should have a functional IT infrastructure and lab information management system. The new digital tools must have an open interface and be interoperable with the existing systems. Although digitalization tools have been available for two decades, few institutions have fully adopted it due to the lack of interoperability. The transition will be gradual, with interoperability playing a crucial role. In the long run, advances in medicine will drive pathologists to adopt digital tools, but they must be user-friendly, robust, and standardized.

Let us know what you think of the episode and any topics you would like us to cover in the future by sending us an email at: podcasts@visiopharm.com or contacting us on social media.